ScanBalt Business Portrait: Oslo Cancer Cluster
Oslo Cancer Cluster is a non-profit member organization dedicated to accelerate the development of new cancer diagnostics and medicines through: Local collaboration and international partnerships; Stimulation and support of new innovations and start-up activities; strengthening of our member’s ability to attract capital; Improved clinical trial efficiency for our members; Increase of governmental focus and improved public policies for the cancer community, fostering and attracting the next generation of top talents to cancer R&D and entrepreneurship.
In June 2007, the cluster became a Norwegian Centre of Expertise (NCE). Oslo Cancer Cluster has more than 70 members from Northern Europe, representing the entire oncology value chain from bench to bedside.
ScanBalt News
19 February 2025
Unlocking Opportunities: Latest Trends & Developments in Sweden’s Life Sciences & Health Sectors | 7 March 2025, 10:00-11:00 CET (online)
18 October 2024
Unlocking Europe's Potential in Bioproduction | 12 November 2024 | 10:30-12:00 CET (online)
10 October 2024
NOME Startup Competition 2024 | Dealine November 1st